Carcinoma, Hepatocellular: all 3,251 studies
Page 6 of 33. Open to participants first (976), then studies with results posted, then the rest; newest registration first within each.
- Triple Therapy for Intermediate-advanced HCC With BDTT (TALENP002)RecruitingNCT06602011
- A Study to Evaluate ALN-BCAT in Patients With Hepatocellular CarcinomaRecruitingNCT06600321Phase 1
- Atezolizumab and BEvacizumab With STereotactic Body Radiotherapy for Advanced Hepatocellular CarcinomaRecruitingNCT06595108Not applicable
- Endoscopic Variceal Ligation vs Carvedilol for the Prevention of First Esophageal Variceal Bleeding in Patients With HCCRecruitingNCT06594744Phase 4
- TACE With Thermosensitive Nanogel Versus Embosphere for HCCRecruitingNCT06593964Not applicable
- Second-line Systemic Therapy Combined with SBRT for HCC with Oligoprogression After Standard First-line Systemic TreatmentNot yet recruitingNCT06592612Phase 2
- Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple MyelomaRecruitingNCT06582017Phase 1
- Postoperative Adjuvant Therapy of Donafenib for Hepatocellular CarcinomaRecruitingNCT06581315Not applicable
- Title of Manuscript: Development and Internal-external Validation of a Comprehensive Model for Predicting Risk of Post-RFA Recurrence in HCC PatientsRecruitingNCT06577272
- Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular CarcinomaRecruitingNCT06571396
- Neoadjuvant Triple Therapy for Resectable HCCRecruitingNCT06569498
- Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)RecruitingNCT06561399
- CT011 Autologous CAR-T Cells in Patients With Hepatocellular Carcinoma at Risk of Recurrence After Surgical ResectionRecruitingNCT06560827Phase 1
- Image Driven Hepatocellular Carcinoma Invasiveness Evaluation ResearchRecruitingNCT06559761
- Study of ZG005 Combined With Bevacizumab Versus Sintilimab Combined With Bevacizumab in Advanced Hepatocellular CarcinomaRecruitingNCT06558227Phase 2
- Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCCRecruitingNCT06553885Phase 2
- Microbiota Modification for Immuno-oncology in Hepatocellular CarcinomaRecruitingNCT06551272Phase 2
- Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular CarcinomaRecruitingNCT06550921Not applicable
- A Study of Camrelizumab Plus Apatinib as Adjuvant Therapy in Patients With Hepatocellular Carcinoma at High Risk of Recurrence After Radical Resection or AblationNot yet recruitingNCT06546280Phase 2
- Imjudo & Imfinzi PMSRecruitingNCT06544629
- Early-stage Detection of Liver Cancer by Proteins in Peripheral BloodRecruitingNCT06544083
- Transfemoral Versus Transradial Approach in Transarterial Chemoembolization of Hepatocellular CarcinomaNot yet recruitingNCT06543030
- Study on the Classification of Comprehensive Treatment Effect of Hepatocellular CarcinomaRecruitingNCT06542796Not applicable
- Psychoeducational Intervention for Patients With Hepatocellular CarcinomaRecruitingNCT06541990Not applicable
- Application of Integrated Proteomic and Serum Metabolomic Analysis in Assessing the Efficacy and Prognosis of TACE Combined With Targeted Immunotherapy in Unresectable Hepatocellular CarcinomaEnrolling by invitationNCT06540508
- SBRT Combined With Adbelimumab and Apatinib for Perioperative and Conversion Therapy of Hepatocellular CarcinomaNot yet recruitingNCT06538935Phase 2
- Anti-PD-1/PD-L1 Antibodies Plus Anti-VEGF Antibody Treatment in Patients With Advanced-Stage HCCRecruitingNCT06537908
- Abbreviated MRI Using Gadoxetic Acid Versus CT for Surveillance of Recurrent HCC After Curative TreatmentRecruitingNCT06537193Not applicable
- A Phase 2, Single Arm Study of Cabozantinib in Patients With Hepatocellular Carcinoma Who Have Received Prior Atezolizumab and BevacizumabNot yet recruitingNCT06535737Phase 2
- Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular CarcinomaNot yet recruitingNCT06530784Phase 2
- A Study of AK112 in Patients With Advanced Hepatocellular Carcinoma (HCC)RecruitingNCT06530251Phase 1/2
- Clinical Pharmacogenetic Study of Sorafenib in Egyptian Patients With Hepatocellular CarcinomaRecruitingNCT06527495Phase 1/2
- A Phase 1 Study of BST02 in Treating Locally Advanced Liver CancerRecruitingNCT06526832Phase 1
- Adjuvant IP-001 Treatment for HCC Patients Following Surgical Resection and Ablation or Ablation AloneRecruitingNCT06526338Phase 2
- Study of Tremelimumab and Durvalumab (MEDI4736) (T300+D) in Advanced Hepatocellular Carcinomas With Child-Pugh-B CirrhosisRecruitingNCT06526104Phase 2
- Prediction of Decompensation and HCC Development in Advanced Chronic Liver DiseaseRecruitingNCT06523608
- Prospective Real-World Study of HAIC With Raltitrexed or 5-Fluorouracil for the Treatment of Hepatocellular CarcinomaRecruitingNCT06519578Not applicable
- A Pilot Study on the Effect of Cannabis Oil in Untreatable Liver Cancer PatientsRecruitingNCT06518434Phase 2
- HRYZ-T102 TCR-T Cell for AFP Positive Advanced HCC and Other Solid TumorsRecruitingNCT06515314Phase 1
- Donafenib Combine With Sintilimab and HAIC in Neoadjuvant of Resectable Hepatocellular CarcinomaNot yet recruitingNCT06512467Phase 2
- A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid TumorsRecruitingNCT06508307Phase 1
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer DetectionRecruitingNCT06503146Phase 2
- Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With EnvafolimabRecruitingNCT06498622Phase 2
- Donafenib Combined With Immunotherapy and Local Therapy for Unresectable Hepatocellular Carcinoma That Has Failed in Previous TherapyNot yet recruitingNCT06496815Phase 4
- Neoadjuvant Intra-tumor Double Immunotherapy for Hepatocellular Carcinoma.RecruitingNCT06492408Phase 2
- Lenvatinib Plus DEB-TACE and HAIC Vs. Lenvatinib Plus DEB-TACE for Large HCC with PVTTRecruitingNCT06492395Phase 3
- TACE Combined With Immune Checkpoint Inhibitors for Liver Malignant TumorsRecruitingNCT06487663Not applicable
- Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)RecruitingNCT06486454
- Prediction and Prognostic Analysis of Liver Abscess Formation After Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma (CHANCE 2407)Not yet recruitingNCT06483594
- HAIC Combined With Adebrelimab Plus Apatinib as the First-line Treatment for HCC in BCLC Stage C: An Open-label, Single-arm, Phase II StudyNot yet recruitingNCT06482008Phase 2
- Backline Treatment of Advanced Hepatocellular Carcinoma With PalbociclibRecruitingNCT06478927Not applicable
- To Evaluate Safety and Efficacy of FB-1603 in Hepatocellular Carcinoma Patient Receiving Transarterial ChemoembolizationRecruitingNCT06478719Phase 1/2
- A Study of MT-303 in Adults With Advanced or Metastatic GPC3-Expressing Cancers, Including HCCRecruitingNCT06478693Phase 1
- HAIC Combined With TQB2450 and Anlotinib in Second-line Treatment of Advanced Hepatocellular CarcinomaNot yet recruitingNCT06475287Phase 2
- Comparison of Serum Myokine Dosages and Imaging Methods in the Evaluation of Sarcopenia in Patients With Hepatocellular CarcinomaRecruitingNCT06475118Not applicable
- Palliative Hepatectomy Combined With Targeted Therapy and Immunotherapy for Advanced Hepatocellular CarcinomaRecruitingNCT06470256Phase 1
- Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCCRecruitingNCT06467799Phase 2
- Anti-cancer Potentiality of Saffron Against Hepatocellular CarcinomaNot yet recruitingNCT06464380Phase 4
- Safety and Efficacy of Autologous Tumor-infiltrating Lymphocytes Therapy in Patients With Hepatocellular CarcinomaRecruitingNCT06463522Phase 1/2
- Clinical Trial of Autologous GPC3 CAR-T Cells (CBG166) Therapy for Advanced Hepatocellular CarcinomaRecruitingNCT06461624Phase 1
- Adjuvant Adebrelimab Plus Apatinib for Participants With HCC at High-risk of Recurrence After Curative ResectionRecruitingNCT06454578Phase 2
- Compare the Accuracy of ctDNA-MRD and MVI Result in Predicting Postoperative Recurrence of Hepatocellular CarcinomaNot yet recruitingNCT06449846
- Fruquintinib After ICIs Treatment in Unresectable Hepatocellular CarcinomaRecruitingNCT06446154Phase 2
- Efficacy and Safety of HAIC in Combination With TQB2868 and Ramucirumab for Second-line Treatment of Advanced Hepatocellular CarcinomaNot yet recruitingNCT06441019Phase 2
- A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid TumorsRecruitingNCT06427941Phase 1/2
- Clinical Effectiveness of Microwave Ablation Using Starwave Microwave Generator for Hepatic MalignanciesRecruitingNCT06426992Not applicable
- PD-1/PD-L1 Inhibitors and Anti-angiogenic Therapy Combined With/Without TACE/HAIC in Patients With BCLC B/C Hepatocellular Carcinoma Beyond Up-to-7Not yet recruitingNCT06423144
- A Value-Driven Study on Reducing Immune Checkpoint Inhibitor Dosing Frequency in Advanced CancersRecruitingNCT06422403Phase 2
- A Clinical Trial Evaluating the Safety and Efficacy of Intravenous CD-801 in Treating Advanced HCC PatientsRecruitingNCT06418659Early Phase 1
- FOLFOX Plus Lenvatinib Adjuvant Therapy for Hepatocellular Carcinoma Post-Liver TransplantationNot yet recruitingNCT06409637Phase 1/2
- Cadonilimab in Combination With Lenvatinib and Hepatic Arterial Infusion Chemotherapy (HAIC) for the Treatment of Unresectable Hepatocellular CarcinomaRecruitingNCT06406634Phase 2
- Conversion or Neoadjuvant Therapy in Hepatocellular CarcinomaRecruitingNCT06405321
- Clinical Trial of TB511 in Advanced Solid TumorsNot yet recruitingNCT06400160Phase 1/2
- DEB-TACE+RALOX-HAIC vs DEB-TACE for Large HCCRecruitingNCT06397235Phase 2
- Sintilimab Plus Bevacizumab and SIRT for Intermediate-advanced HCCRecruitingNCT06397222Phase 2
- Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor ThrombosisRecruitingNCT06389422Phase 2
- Evaluating the Role of ChatGPT in Educating Patients With Early-stage Hepatocellular CarcinomaRecruitingNCT06384950Not applicable
- Study on the Clinical Application Value of PET Imaging Targeting GPC3 in Hepatocellular CarcinomaRecruitingNCT06383520Early Phase 1
- Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion TherapyRecruitingNCT06382103
- Evaluation of Immune Responses and Outcomes in Patients With Hepatocellular Carcinoma Undergoing RadiotherapyRecruitingNCT06379256
- Ivonescimab Combined With HAIC for the Treatment of Unresectable Hepatocellular Carcinoma（uHCC）.RecruitingNCT06375486Phase 2
- HAIC Combined With PD-L1 Plus Regorafenib in the Treatment of Advanced Hepatocellular Carcinoma After Immunotherapy FailureNot yet recruitingNCT06375317Phase 2
- A Study of AK104+Lenvatinib in Combination With Transarterial Chemoembolization (TACE) Versus TACE in Participants With Incurable/Non-metastatic Hepatocellular CarcinomaRecruitingNCT06371157Phase 3
- Serplulimab Combined With Bevacizumab Biosimilar and HAIC in Advanced Hepatocellular Carcinoma (HCC) PatientsRecruitingNCT06370065Phase 2
- Study on the Efficacy and Safety of Conversion Therapy in Patients With Initially Unresectable Hepatocellular CarcinomaRecruitingNCT06365034
- Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal AntibodyNot yet recruitingNCT06364800Early Phase 1
- Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial for First-line Treatment of Hepatocellular CarcinomaNot yet recruitingNCT06364787Phase 1
- HAIC Combined With Durvalumab and Tremelimumab and Lenvatinib in uHCCRecruitingNCT06364007Phase 2
- A Study of TAE+HAIC Combined With Camrelizumab and Apatinib in the Treatment of Advanced Hepatocellular CarcinomaRecruitingNCT06363825Phase 2
- Combination of Cardonizumab Injection and TKI Second Line Therapy for Advanced Hepatocellular CancerRecruitingNCT06363006Phase 1
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab MonotherapyRecruitingNCT06362369Phase 1/2
- Anti-PD-1/PD-L1 Combined With Anti-angiogenic Agents as First-line Treatment for Unresectable HCCRecruitingNCT06360042Phase 2
- Hepatocellular Carcinoma Liver OrganoidsRecruitingNCT06355700Not applicable
- A Study to Explore the Reasonable Dosage and Evaluate the Efficacy, Safety and Tolerability of HLX10 and HLX04 with or Without HLX53 in Untreated, Locally Advanced or Metastatic Hepatocellular Carcinoma Patients.RecruitingNCT06349980Phase 2
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruitingNCT06349642
- Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTTRecruitingNCT06349317Phase 2
- Early Detection of Liver Cancer by QUSRecruitingNCT06345508
- An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver CancerRecruitingNCT06342414
- Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular CarcinomaRecruitingNCT06339424Phase 2
- Multi-modal Characterisation of Hepatocellular Carcinoma (HCC) Treated with Targeted Radionuclide Therapy (TRT): Prospective Interventional Multicentre National CohortRecruitingNCT06334965Not applicable